education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Dormi Comp
Dormi Comp
Manufacturer:
Zenith Pharmaceuticals
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Hyoscine butylbromide 10 mg, methampyrone 250 mg
Indications/Uses
Renal & gall bladder colic, GI spasm, dysmenorrhea.
Dosage/Direction for Use
1-2 caplet 3 times daily if necessary.
Administration
Should be taken with food: Take immediately after meals.
Contraindications
Hypersensitivity to methampyrone. Patients w/ glaucoma. Pregnancy. Babies <3 mth or weighing <5 kg.
Special Precautions
Patients w/ a history of blood formation disorders.
Adverse Reactions
Skin hypersensitivity, agranulocytosis, drowsiness, dry mouth, tachycardia.
View
ADR Reporting Link
Drug Interactions
Alcohol. MAOIs, metoclopramide.
MIMS Class
Antispasmodics
ATC Classification
A03DB04 - butylscopolamine and analgesics ; Belongs to the class of belladonna and derivatives antispasmodics in combination with analgesics. Used in the treatment of functional gastrointestinal disorders.
Regulatory Classification
K
Presentation/Packing
Form
Dormi Comp caplet
Packing/Price
10 × 10's (Rp535,305/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk